Billions of dollars in U.S. biosimilar erosion to AbbVie’s blockbuster immunology drug Humira is no match for its rising ...

News and commentary from the world of gastroenterology and hepatology ...

A new Crohn's & Colitis Foundation–led survey of more than 1,500 people living with or at risk for inflammatory bowel disease ...

Skin and soft tissue infections are more common in children with Crohn’s disease, especially those receiving combination ...

Boehringer Ingelheim has penned a 1.05 billion euro ($1.26 billion) biobucks deal for Simcere’s preclinical inflammatory bowel disease (IBD) bispecific antibody. | Boehringer Ingelheim has penned a 1.

LGBTQ+ individuals with inflammatory bowel disease experience multiple gaps and inequities in care when managing their ...

For decades, patients with inflammatory bowel disease have reported a familiar and frustrating pattern: periods of intense ...

Normally, PTPN2 helps maintain gut health by controlling inflammation and supporting a balanced gut microbiome. However, some ...

Single-center study finds durable, steroid-free remission, especially in ulcerative coliti ...

After years of operating under an independent broker dealer, many advisors find themselves at an inflection point.